Isabl - Comprehensive Genomic Testing for Cancer Patients
Isabl is a biotech startup spun out of Memorial Sloan Kettering Cancer Center, developing a test that analyzes a tumor's entire genome and transcriptome instead of a limited gene panel — and won an FDA Breakthrough Device Designation in 2021.
Think & Rich